Found: 11
Select item for more details and to access through your institution.
Pharmacokinetics and pharmacodynamics of ponezumab (PF-04360365) following a single-dose intravenous infusion in patients with mild to moderate Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Preliminary population pharmacokinetic modeling of PF-04360365, a humanized anti-amyloid monoclonal antibody, in patients with mild-to-moderate Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Safety and pharmacokinetics of the anti-amyloid monoclonal antibody PF-04360365 following a single infusion in patients with mild-to-moderate Alzheimer's disease: Preliminary results
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Varenicline, an &alpha4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 296, n. 1, p. 47, doi. 10.1001/jama.296.1.47
- By:
- Publication type:
- Article
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Efficacy of varenicline, an alpha4ß2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial [corrected] [published erratum appears in JAMA 2006 Sep 20;296(11):1355].
- Published in:
- 2006
- By:
- Publication type:
- journal article
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Effect of Maintenance Therapy With Varenicline on Smoking Cessation.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 296, n. 1, p. 64, doi. 10.1001/jama.296.1.64
- By:
- Publication type:
- Article
Efficacy of Varenicliner an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 296, n. 1, p. 56, doi. 10.1001/jama.296.1.56
- By:
- Publication type:
- Article
Varenicline Versus Bupropion SR or Placebo for Smoking Cessation: A Pooled Analysis.
- Published in:
- American Journal of Health Behavior, 2008, v. 32, n. 6, p. 664, doi. 10.5993/AJHB.32.6.10
- By:
- Publication type:
- Article
Should troponin and creatinine kinase be routinely measured after vascular surgery?
- Published in:
- Vascular Medicine, 2007, v. 12, n. 3, p. 175, doi. 10.1177/1358863X07081139
- By:
- Publication type:
- Article